Application of graphene/graphene oxide in biomedicine and biotechnology. 2014

Xianfeng Zhou, and Feng Liang

Graphene, a truly two-dimensional (2D) and fully π-conjugated honeycomb network, exhibits many unique physical and chemical properties that are interesting in a wide range of areas. Since its discovery in 2004, graphene has been extensively studied in many different fields including nano-electronics, composite materials, energy research, catalysis and so on. Based on the fascinating action of members in the carbon family, notably zero dimensional (0D) fullerenes and one dimensional (1D) carbon nanotubes (CNTs) in biomedical areas, increasing number of reports have explored the potential of graphene for different biomedical and biotechnical applications since 2008. This manuscript aims to provide a summary of current research progress of graphene-based carbon materials in biosensing, drug (gene) delivery and tissue engineering, and discusses the opportunities and challenges in this rapidly growing field.

UI MeSH Term Description Entries
D010087 Oxides Binary compounds of oxygen containing the anion O(2-). The anion combines with metals to form alkaline oxides and non-metals to form acidic oxides. Oxide
D004337 Drug Carriers Forms to which substances are incorporated to improve the delivery and the effectiveness of drugs. Drug carriers are used in drug-delivery systems such as the controlled-release technology to prolong in vivo drug actions, decrease drug metabolism, and reduce drug toxicity. Carriers are also used in designs to increase the effectiveness of drug delivery to the target sites of pharmacological actions. Liposomes, albumin microspheres, soluble synthetic polymers, DNA complexes, protein-drug conjugates, and carrier erythrocytes among others have been employed as biodegradable drug carriers. Drug Carrier
D006108 Graphite An allotropic form of carbon that is used in pencils, as a lubricant, and in matches and explosives. It is obtained by mining and its dust can cause lung irritation. Graphene
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001709 Biotechnology Body of knowledge related to the use of organisms, cells or cell-derived constituents for the purpose of developing products which are technically, scientifically and clinically useful. Alteration of biologic function at the molecular level (i.e., GENETIC ENGINEERING) is a central focus; laboratory methods used include TRANSFECTION and CLONING technologies, sequence and structure analysis algorithms, computer databases, and gene and protein structure function analysis and prediction. Biotechnologies
D015374 Biosensing Techniques Any of a variety of procedures which use biomolecular probes to measure the presence or concentration of biological molecules, biological structures, microorganisms, etc., by translating a biochemical interaction at the probe surface into a quantifiable physical signal. Bioprobes,Biosensors,Electrodes, Enzyme,Biosensing Technics,Bioprobe,Biosensing Technic,Biosensing Technique,Biosensor,Electrode, Enzyme,Enzyme Electrode,Enzyme Electrodes,Technic, Biosensing,Technics, Biosensing,Technique, Biosensing,Techniques, Biosensing
D050997 Nanomedicine The branch of medicine concerned with the application of NANOTECHNOLOGY to the prevention and treatment of disease. It involves the monitoring, repair, construction, and control of human biological systems at the molecular level, using engineered nanodevices and NANOSTRUCTURES. (From Freitas Jr., Nanomedicine, vol 1, 1999).
D023822 Tissue Engineering Generating tissue in vitro for clinical applications, such as replacing wounded tissues or impaired organs. The use of TISSUE SCAFFOLDING enables the generation of complex multi-layered tissues and tissue structures. Engineering, Tissue

Related Publications

Xianfeng Zhou, and Feng Liang
April 2021, Nanomaterials (Basel, Switzerland),
Xianfeng Zhou, and Feng Liang
May 2011, Trends in biotechnology,
Xianfeng Zhou, and Feng Liang
January 2006, Molekuliarnaia biologiia,
Xianfeng Zhou, and Feng Liang
September 2021, Nanomaterials (Basel, Switzerland),
Xianfeng Zhou, and Feng Liang
January 2019, American journal of translational research,
Xianfeng Zhou, and Feng Liang
January 2001, Journal of biomedicine & biotechnology,
Xianfeng Zhou, and Feng Liang
August 2016, Journal of biotechnology,
Xianfeng Zhou, and Feng Liang
March 2014, Biosensors,
Xianfeng Zhou, and Feng Liang
August 2013, Chemistry (Weinheim an der Bergstrasse, Germany),
Xianfeng Zhou, and Feng Liang
April 2019, Trends in biotechnology,
Copied contents to your clipboard!